Jeff began advising Claritas in 2016 after serving as President of ReproSource Diagnostics from 2014 to 2015. From 1995 to 2009, Jeff was Chief Financial Officer and Senior Vice President of Athena Diagnostics and then appointed General Manager, a position he held from 2009 through 2014.
Athena Diagnostics is the nations leading esoteric neurological testing company. During his time at Athena, Jeff successfully managed the company through its period of most significant growth, which resulted in his leading the sale of the company to numerous industry leaders, including Thermo Fisher Scientific and more recently, Quest Diagnostics, within which Athena now operates as the Center of Excellence for Neurology. Jeff continued to run Athena after each of these and other acquisitions and served as a member of the senior management of the parent corporations.
Prior to joining Athena, Jeff was, from 1985 to 1995, the Chief Financial Officer of Colorgen and prior to that, from 1979 to 1985, held several positions of increasing responsibility with the Big Eight accounting firm of Touche Ross, currently known as Deloitte & Touche. Jeff holds a bachelors degree in business from the University of Massachusetts at Amherst, where he graduated summa cum laude.